- Oops!Something went wrong.Please try again later.
SCOTTSDALE, AZ / ACCESSWIRE / December 8, 2020 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announced today that the company will be introducing another new product. This product is 3 different variations of CBD seeds & they will be available to purchase next week!
One seed we are working with is Berry Blossom. Berry Blossom comes from parents Chardonnay and Cherry Kandahar S1. Obviously, with such flavorful lineage, Cherry Blossom's popularity is apparent. Its Chardonnay ancestry develops beautiful, deep green buds with distinct purple and blue hues. Likely, this is due to the Black Rose in its genetics. At maturity, aromas of berry, pine, and cheese fill the air. Indeed, this pungent perfume gives a clear indication of its dense terpene content. Chardonnay is relatively low in CBD compared to other cannabinoid hemp varieties. However, the sheer beauty of Chardonnay ensures consistent market attraction. These seeds produce small to medium-sized plants that develop rather quickly compared to other CBD hemp strains. Growers can expect to harvest this indica strain within about eight or nine into flower.
Another seed we are working with is Sagan. Sagan is a true CBG with stable production and absolutely zero THC production. With homogenous growth, stable potency, consistent production and agricultural pricing, Sagan is the true CBG answer for agricultural production of CBG hemp. Sagan was produced through the work of both the labs of the agricultural Universities of Spain and the farms of Southern Spain. As an agricultural center of Europe, Spanish universities have long been at the forefront of genetic research for plants and food crops. Located southwest of Valencia, the fields of Bolbaite have been Europe's supplier of a large variety of citrus, tomatoes, and nut crops for centuries. The union of these cutting-edge researchers & scientists and these generational farmers has produced Sagan, a field and lab proven CBG hemp varietal never before made available to the public.
Lastly, we have Tsunami. Auto Tsunami is recommended for greenhouse production where blackout curtains (day neutral variety) are not in use. The cultivar produces short, bushy plants with a high flower to shoot/leaf ratio. Hemp flowers are large, bright green, and expansive with white pistils.
Why Shop LBC Bioscience?
Free Shipping on All Orders for the Holidays
Large Selection of Products (over 50 items and growing)
100% USA Made Products "organic & kosher"
30% off on all products through the Holidays using code "LBC30"
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com: